Schellart R P, Schouten W R, Huikeshoven F J
Department of Obstetrics and Gynecology, Academic Hospital Rotterdam Dijkzigt, The Netherlands.
Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):77-80. doi: 10.1007/BF01902377.
The incidence of relaxation of the pelvic floor increases with age, and although a relation between prolapse and the decline of estrogens has been suggested, there is no objective evidence. Together with urodynamic measurements, anal manometry is one of the few ways of making an objective assessment of the strength of pelvic structures located in and near the pelvic floor. In order to study the role of estrogens, anal manometry was performed before, during and after estrogen replacement therapy with daily oral use of 0.625 mg conjugated estrogens for 6 months. Five postmenopausal women, who had not used estrogen replacement therapy in the past, were included in the study. None of the manometric parameters, including maximal anal resting pressure, maximal squeeze pressure and internal anal sphincter response, changed. It was concluded that estrogens have no effects on manometric parameters of the external sphincter and that anal manometry may not be the appropriate method to assess the effects of estrogens on the pelvic floor.
盆底松弛的发生率随年龄增长而增加,尽管有人提出脱垂与雌激素水平下降之间存在关联,但尚无客观证据。与尿动力学测量一样,肛门测压是对位于盆底及其附近的盆腔结构强度进行客观评估的少数方法之一。为了研究雌激素的作用,在每日口服0.625mg共轭雌激素进行6个月雌激素替代治疗之前、期间和之后进行了肛门测压。研究纳入了5名过去未使用过雌激素替代治疗的绝经后妇女。包括最大肛门静息压、最大收缩压和肛门内括约肌反应在内的所有测压参数均未改变。得出的结论是,雌激素对外括约肌的测压参数没有影响,并且肛门测压可能不是评估雌激素对盆底影响的合适方法。